WE ARE THE GLOBAL LEADERS

Chemotherapy-induced hair loss is widely recognised as one of the most traumatic side effects associated with cancer treatment, and yet it is still one of the least explored. We are changing that.

Paxman has been pioneering scalp cooling technology for over a quarter of a century. Our clinically proven cold cap system has helped over 100,000 cancer patients in more than 25 countries worldwide to retain their hair during chemotherapy.

Read our statement on working during COVID19

Paxman Hub

100K+

PATIENTS TREATED

Paxman Hub

32

COUNTRIES WORLDWIDE

Paxman Hub

1

PATIENT CHOICE

PATIENTS

Are you looking for patient information?

PRACTICE

Are you looking for clinical and technical information?

RESEARCH

The science and development behind scalp cooling.

ABOUT US

Find out all about Paxman the family business.